Clinical Trials Browser

INDUSTRY × cediranib × Other hematologic neoplasm × Clear all

NCT00502385 2011-01-21

Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML

Phase 1 Completed

Other hematologic neoplasm

Leukemia